Diamond, J. M., Vos, R., Budev, M., Goldberg, H. J., Criner, G. J., Pilewski, J. M., … Palmer, S. M. (2022). Efficacy and Safety of the Janus Kinase 1 Inhibitor Itacitinib (ITA) in Patients with Bronchiolitis Obliterans (BOS) Syndrome Following Double Lung Transplant. In JOURNAL OF HEART AND LUNG TRANSPLANTATION (Vol. 41, pp. S113–S113).

Diamond, J. M., R. Vos, M. Budev, H. J. Goldberg, G. J. Criner, J. M. Pilewski, L. G. Singer, et al. “Efficacy and Safety of the Janus Kinase 1 Inhibitor Itacitinib (ITA) in Patients with Bronchiolitis Obliterans (BOS) Syndrome Following Double Lung Transplant.” In JOURNAL OF HEART AND LUNG TRANSPLANTATION, 41:S113–S113, 2022.

Diamond JM, Vos R, Budev M, Goldberg HJ, Criner GJ, Pilewski JM, et al. Efficacy and Safety of the Janus Kinase 1 Inhibitor Itacitinib (ITA) in Patients with Bronchiolitis Obliterans (BOS) Syndrome Following Double Lung Transplant. In: JOURNAL OF HEART AND LUNG TRANSPLANTATION. 2022. p. S113–S113.

Diamond, J. M., et al. “Efficacy and Safety of the Janus Kinase 1 Inhibitor Itacitinib (ITA) in Patients with Bronchiolitis Obliterans (BOS) Syndrome Following Double Lung Transplant.” JOURNAL OF HEART AND LUNG TRANSPLANTATION, vol. 41, no. 4, 2022, pp. S113–S113.

Diamond JM, Vos R, Budev M, Goldberg HJ, Criner GJ, Pilewski JM, Singer LG, Weigt SS, Lakshminarayanan M, Schaub RL, O’Hayer K, Palmer SM. Efficacy and Safety of the Janus Kinase 1 Inhibitor Itacitinib (ITA) in Patients with Bronchiolitis Obliterans (BOS) Syndrome Following Double Lung Transplant. JOURNAL OF HEART AND LUNG TRANSPLANTATION. 2022. p. S113–S113.